U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 52

Tests names and labsConditionsGenes, analytes, and microbesMethods

PABPN1 - Repeat expansion analysis

Centogene US, LLC - The Rare Disease Company
United States
11
  • T Targeted variant analysis

PABPN1 - Repeat expansion analysis

Centogene AG - the Rare Disease Company
Germany
11
  • T Targeted variant analysis

Oculopharyngeal muscular dystrophy, 164300, Autosomal dominant; OPMD (Oculopharyngeal muscular dystrophy)(Repeat Analysis)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • T Targeted variant analysis

Oculopharyngeal muscular dystrophy, 164300, Autosomal dominant; OPMD (Oculopharyngeal muscular dystrophy) (Prenatal)(Repeat Analysis)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • T Targeted variant analysis

Oculopharyngeal Muscular Dystrophy via the PABPN1 (GCN) Repeat Expansion

PreventionGenetics
United States
11
  • E Sequence analysis of select exons

PABPN1. GCG expansion detection by PCR

IGENOMIX
Spain
11
  • T Targeted variant analysis

Oculopharyngeal muscular dystrophy

Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba
Canada
11
  • T Targeted variant analysis

Muscular Dystrophy, Myopathy and Myasthenia Panel

Mendelics
Brazil
391
  • C Sequence analysis of the entire coding region

MUSCULAR DISORDERS- EMCG GLOBAL EXOME PANEL

Laboratorio de Genetica Clinica SL
Spain
1416
  • E Sequence analysis of select exons

ARTHROGRIPOSIS PANEL

Laboratorio de Genetica Clinica SL
Spain
1245
  • E Sequence analysis of select exons

MUSCULAR DYSTROPHIES/ MYOPATHIES PANEL

Laboratorio de Genetica Clinica SL
Spain
1250
  • E Sequence analysis of select exons

MITOCHONDRIAL DISEASES PANEL (NUCLEAR GENES)

Laboratorio de Genetica Clinica SL
Spain
11372
  • E Sequence analysis of select exons

Genetic Test for oculopharyngeal muscular dystrophy

CGPP - Center for Predictive and Preventive Genetics IBMC - Institute for Cell and Molecular Biology
Portugal
11
  • D Deletion/duplication analysis

Skeletal diseases. NGS panel of 169 genes.

Genologica Medica
Spain
374169
  • C Sequence analysis of the entire coding region

Genomic Unity® Custom Analysis

Variantyx, Inc.
United States
14054
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Xpanded Adult Movement Disorders Panel

GeneDx
United States
5473
  • C Sequence analysis of the entire coding region

Comprehensive Ophthalmoplegia Syndromes (NGS Panel and Copy Number Analysis + mtDNA)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
1052
  • C Sequence analysis of the entire coding region

Non-mitochondrial Comprehensive Ophthalmoplegia Syndromes (NGS Panel and Copy Number Analysis)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
429
  • C Sequence analysis of the entire coding region

Myopathies, including congenital myopathies (WES based NGS panel of 180 genes, including CNV analysis)

Unilabs Genetics CGC Genetics
Portugal
316180
  • C Sequence analysis of the entire coding region

Oculopharyngeal muscular dystrophy (GCG expansion on PABPN1 gene)

Unilabs Genetics CGC Genetics
Portugal
11
  • T Targeted variant analysis

Results: 1 to 20 of 52

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.